Researchers demonstrated that declining Hedgehog signaling from Cilk1 loss produces stepwise changes in tooth formation ...

MHT CET registration link will be made active today and candidates can apply till February 12. Check the complete timeline ...

“We were able to causally link a specific brain pathway to a ‘brake’ on motivation when individuals face unpleasant tasks in ...

Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows sex-based differences, with women being more at risk. However, the origin ...

For more information, please visit the conference website here.

Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced new data demonstrating that its combination therapy of ...

Alzheimer’s disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines -- 25+ years of biotherapeutics leadership, including serving as ...

A new meeting report was published in Volume 17, Issue 12 of Aging-US on December 23, 2025, titled "Cellular senescence meets ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion of its Scientific Advisory ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...